✦ LIBER ✦

Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective

✍ Scribed by Anthony Bentley, Samantha Gillard, Michael Spino, John Connelly…

Book ID: 120807457
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 747 KB
Volume: 31
Category: Article
ISSN: 1170-7690
DOI: 10.1007/s40273-013-0076-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Cost–Utility Analysis of Def

Erratum to: Cost–Utility Analysis of Deferiprone for the Treatment of β-Thalassaemia Patients with Chronic Iron Overload: A UK Perspective

✍ Bentley, Anthony; Gillard, Samantha; Spino, Michael; Connelly, John; Tricta, Fer 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 204 KB

PSY8 BUDGET IMPACT ANALYSIS OF DEFERASIR

PSY8 BUDGET IMPACT ANALYSIS OF DEFERASIROX FOR THE TREATMENT OF CHRONIC IRON OVERLOAD IN PATIENTS WITH BETATHALASSAEMIA IN VENETO REGION, ITALY

✍ F Venturini; S Adami; C Alberti; G Scroccaro 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

S1025 A Cost-Utility Analysis of Inflixi

S1025 A Cost-Utility Analysis of Infliximab Compared with Surgery for the Treatment of Ulcerative Colitis; A Public Payer Perspective

✍ Jennifer Jones; Lawrence Worobetz; Anil Bedi; Braden Manns 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 88 KB

PCN42 A SENSITIVITY ANALYSIS ON THE COST

PCN42 A SENSITIVITY ANALYSIS ON THE COST UTILITY OF BEVACIZUMAB, CAPECITABINE, AND OXALIPLATIN COMPARED WITH FOLFOX FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER (CRC): A UK PERSPECTIVE

✍ P Ducournau; G Lewis; A McDonald; DR Millar; E Sabate; S Walzer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PIN9 A COST UTILITY ANALYSIS OF PEGINTER

PIN9 A COST UTILITY ANALYSIS OF PEGINTERFERON ALFA-2A (40 KD) VERSUS PEGINTERFERON ALFA-2B (I2KD) FOR THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN THE UK

✍ NR Latimer; GJ Lewis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Cost–utility analysis of different peg-i

Cost–utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C

✍ W.-A. LIN; Y.-H. TARN; S.-L. TANG 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB